The Cancer Immunotherapy Market was valued at approximately USD 120 billion in 2023 and is expected to grow at a substantial CAGR of around 10% during the forecast period (2024-2032) Since 2000, cancer immunotherapy has been considered the most revolutionary method in the field of oncology and has changed the cancer treatment paradigm. Companies have developed a promising type of treatment that...